Technical Analysis for PTI - Proteostasis Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
PTI closed up 5.8 percent on Friday, June 22, 2018, on 4.36 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical PTI trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 22||Volume Surge||Other||0.00%|
|Jun 22||Wide Bands||Range Expansion||0.00%|
|Jun 22||Oversold Stochastic||Weakness||0.00%|
|Jun 21||Wide Bands||Range Expansion||5.80%|
|Jun 21||Oversold Stochastic||Weakness||5.80%|
|Jun 20||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||1.64%|
|Jun 20||Narrow Range Bar||Range Contraction||1.64%|
|Jun 20||Wide Bands||Range Expansion||1.64%|
|Jun 20||Oversold Stochastic||Weakness||1.64%|
|Jun 19||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||1.31%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. Its lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. The company was founded in 2006 and is based in Cambridge, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PTI news...
|52 Week High||8.61|
|52 Week Low||1.41|
|200-Day Moving Average||3.7086|
|50-Day Moving Average||4.5738|
|20-Day Moving Average||3.7255|
|10-Day Moving Average||2.968|
|Average True Range||0.2959|
|Chandelier Exit (Long, 3 ATRs )||4.2723|
|Chandelier Exit (Short, 3 ATRs )||3.5677|
|Upper Bollinger Band||5.5879|
|Lower Bollinger Band||1.8631|
|Percent B (%b)||0.33|
|MACD Signal Line||-0.4969|
|Market Cap||77.81 Million|
|Num Shares||25.1 Million|
|Price-to-Earnings (P/E) Ratio||-1.42|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||3.60|
|Resistance 3 (R3)||3.57||3.37||3.51|
|Resistance 2 (R2)||3.37||3.25||3.39||3.48|
|Resistance 1 (R1)||3.24||3.17||3.31||3.27||3.46|
|Support 1 (S1)||2.91||2.92||2.98||2.94||2.74|
|Support 2 (S2)||2.71||2.84||2.73||2.72|
|Support 3 (S3)||2.58||2.71||2.69|
|Support 4 (S4)||2.61|